NEOPLASMA
Zoznam článkov
Volume 62, 2015, No. 1
ISSN 0028-2685 (print)
ISSN 1338-4317 (online)
Obsah:
- YU, H. - Shen, Y. - HONG, J. - XIA, Q. - ZHOU, F. - LIU, X.: The contribution of TGF-β in Epithelial–Mesenchymal Transition (EMT): Down-regulation of E-cadherin via snail. (s. 1)
- Zhang, L. - WANG, H. - XU, J.: Cathepsin S as a cancer target. (s. 16)
- GORANOVA, T. - BOZHANOV, S. - LOZANOV, V. - MITEV, V. - KANEVA, R. - GEORGIEVA, E.: Changes in gene expression of CXCR4, CCR7 and BCL2 after treatment of breast cancer cells with saponin extract from Tribulus terrestris. (s. 27)
- QU, Y. - ZHANG, X. - WU, R.: Knockdown of NF-κB p65 subunit expression suppresses growth of nude mouse lung tumor cell xenografts by activation of Bax apoptotic pathway. (s. 34)
- JANDOVA, J. - MASON, C. - PAWAR, S. - WATTS, G.: Fn14 receptor promotes invasive potential and metastatic capacity of non-small lung adenocarcinoma cells through the up-regulation of integrin α6. (s. 41)
- ZHOU, W. - MA, C. - YAN, Z.: Microarray data analysis reveals differentially expressed genes in prolactinoma. (s. 53)
- LIU, Y. - CHEN, X. - GU, Y. - ZHU, L. - QIAN, Y. - PEI, D. - Zhang, W. - SHU, Y.: FOXM1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and mediates sensitivity to cisplatin in A549 cells via the JNK/mitochondrial pathway. (s. 61)
- KOMMINENI, N. - JAMIL, K. - PINGALI, U. - ADDALA, L. - M., V. - NAIDU, M.: Association of PIK3CA gene mutations with head and neck squamous cell carcinomas. (s. 72)
- Dang, S. - Feng, S. - WANG, P. - Cui, L. - Qu, J. - Zhang, J.: Overexpression of Survivin mutant Thr34Ala induces apoptosis and inhibits gastric cancer growth. (s. 81)
- FURJELOVA, M. - KOVALSKA, M. - JURKOVA, K. - CHYLIKOVA, J. - MESTANOVA, V. - ADAMKOV, M.: Correlation of carbonic anhydrase IX expression with clinico-morphological parameters, hormonal receptor status and HER-2 expression in breast cancer. (s. 88)
- KRAJNAKOVA, L. - PAULIKOVA, H. - BACOVA, Z. - BAKOS, J. - JANOVEC, L. - IMRICH, J. - HUNAKOVA, L.: Intracellular distribution of 3,6-bis(3-alkylguanidino)acridines determines their cytotoxicity. (s. 98)
- WANG, W. - YAN, H. - TIAN, F. - SU, Y. - XU, J. - DOU, C.: Associations between the Expression of micro-RNA 214 and clinicopathologic parameters of glioma. (s. 108)
- SOUMAROVA, R. - BODAY, A. - KRHUTOVA, V. - JANOTOVA, A. - DVORAKOVA, M. - JALUVKOVA, E. - ŠTURSA, M. - PERKOVÁ, H.: Prognostic and predictive molecular biological markers in prostate cancer – significance of expression of genes PCA3 and TMPRSS2. (s. 114)
- SZEWCZYK-GOLEC, K. - TYLOCH, J. - CZUCZEJKO, J.: Antioxidant defense system in prostate adenocarcinoma and benign prostate hyperplasia of elderly patients. (s. 119)
- SONG, X. - WANG, S. - WANG, Z. - CAO, W. - L., J. - CHEN, F.: Serum CYFRA21-1 as an effective tumor biomarker for patients with nasopharyngeal carcinoma. (s. 124)
- KUGLIK, P. - KASIKOVA, K. - Smetana, J. - VALLOVA, V. - LASTUVKOVA, A. - MOUKOVA, L. - Cvanova, M. - BROZOVA, L.: Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas. (s. 130)
- DVORAK, P. - LYSAK, D. - VOKURKA, S. - KARAS, M. - SUBRT, I.: Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment. (s. 140)
- SZOTKOWSKI, T. - FABER, E. - HUBACEK, J. - RAIDA, L. - ROHON, P. - KUBA, A. - PIKALOVA, Z. - HOLZEROVA, M. - DIVOKA, M. - JAROSOVA, M. - VRBKOVA, J. - PAPAJIK, T. - INDRAK, K.: Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experienc. (s. 146)
- HAN, L. - LIU, W. - CHEN, Y. - WU, H. - ZHANG, Y. - Jiang, B.: GROα expression and its prognostic implications in laryngeal squamous cell carcinoma. (s. 152)
- ONDRUS, D. - ONDRUSOVA, M. - KAJO, K.: Management of patients with clinical stage I nonseminomatous germ cell testicular cancer: Active surveillance versus adjuvant chemotherapy – single-centre experience. (s. 159)